cyproterone acetate has been researched along with flutamide in 172 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 43 (25.00) | 18.7374 |
1990's | 60 (34.88) | 18.2507 |
2000's | 51 (29.65) | 29.6817 |
2010's | 18 (10.47) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ackerman, JH; Bell, MR; Christiansen, RG; D'Ambra, TE; Herrmann, JL; Kullnig, RK; Mallamo, JP; Opalka, CJ; Snyder, BW; Winneker, RC | 1 |
Abraham, DJ; Lin, HR | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Kastelan, M; Kraljić, I; Tarle, M | 1 |
Van Cangh, PJ | 1 |
Benten, WP; Mossmann, H; Wunderlich, F | 1 |
Schmeller, N | 1 |
Imai, K; Kawashima, K; Nakata, S; Shimizu, N; Suzuki, T; Takahashi, O; Watanabe, K; Yamanaka, H | 1 |
Radoś, N; Tarle, M | 1 |
el Etreby, MF; Habenicht, UF; Neumann, F | 1 |
Schulze, H; Senge, T | 1 |
D'Eramo, G; Di Silverio, F; Sciarra, F | 1 |
Schröder, FH | 3 |
Concolino, G; Di Silverio, F; Sciarra, F; Toscano, V | 1 |
Arbusow, V; Bojar, H; Fittler, F; Klobeck, HG; Schulz, P; Wolf, D | 1 |
Cusan, L; Labrie, C; Labrie, F; Lapointe, S; Plante, M | 1 |
Concolino, G; Conti, C; Di Silverio, F; Lubrano, C; Petrangeli, E; Sciarra, F; Toscano, V | 1 |
Labrie, F; Lapointe, S; Plante, M | 1 |
Le Guellec, R; Léger, JG; Tenniswood, MP | 1 |
Namer, M | 1 |
Baylink, DJ; Farley, JR; Kasperk, CH; Linkhart, TA; Turner, RT; Wergedal, JE | 1 |
Shaw, CJ; Snyder, BW; Wagner, MM; Winneker, RC | 1 |
Waxman, J | 1 |
Milsted, RA | 1 |
Ganten, D; Ganten, U; Schröder, G; Stock, G; Witt, M; Zimmermann, F | 1 |
Gupta, G; Setty, BS; Srivastava, A | 1 |
Mowszowicz, I | 1 |
Furr, BJ | 2 |
Daricello, G; Pavone, C; Pavone-Macaluso, M; Romano, C; Serretta, V | 1 |
Gangnerau, MN; Picon, R | 1 |
Dias, JA; Swift, TA | 1 |
Abel, P; Cox, J; Farah, N; Fleming, J; Hewitt, G; O'Donoghue, EP; Sandow, J; Sikora, K; Waxman, J; Williams, G | 1 |
Sathyanesan, AG; Shrivastava, VK | 1 |
Sogani, PC; Whitmore, WF | 1 |
Soloway, MS | 1 |
Haider, S; Rai, U | 1 |
Alexandre, C; Balthazart, J | 2 |
Cunningham, GR; Kong, AY; Shao, TC | 1 |
Gutiérrez Cecchini, B; Hidalgo Balsera, A; Manso Rodríguez, G; Sala Blanco, J | 1 |
Fair, WR; Sogani, PC | 1 |
Ayub, M; Levell, MJ | 1 |
Dupront, A; Meyer, BH; Pottier, J; Tremblay, D | 1 |
el Etreby, MF; Habenicht, UF; Louton, T; Nishino, Y; Schröder, HG | 1 |
el Etreby, MF; Habenicht, UF; Neumann, F; Schröder, H | 1 |
Bruchovsky, N; Fletcher, T; Foekens, JA; Goldenberg, SL; Lawson, D; Rennie, PS | 1 |
Donn, F; Tamm, J; Volkwein, U | 1 |
Clos, V; Esteve, A; Jane, F; Salva, P | 1 |
Bouffioux, C | 1 |
Alioth, H; Müller, J; Senn, E | 1 |
Bullock, LP; Ventura, SM | 1 |
Jacobi, GH; Wenderoth, UK | 1 |
Hano, R; Knuth, UA; Nieschlag, E | 1 |
Das, RP; Kumari, GL; Roy, S | 1 |
Rees, J; Shuster, S | 1 |
Lax, ER; Schriefers, H | 1 |
Panse, GT | 1 |
Bruchovsky, N; Gleave, ME; Goldenberg, SL; Jones, EC; Sullivan, LD | 1 |
Ebert, K; Knuppen, R; Michna, H; Vollmer, G | 1 |
Cooper, EH; Purves, D; Whelan, P | 1 |
Bartsch, G; Horninger, W | 1 |
Kumamoto, Y; Nambu, A | 1 |
Biordi, L; Bologna, M; Festuccia, C; Muzi, P; Vicentini, C | 1 |
Hagen, R; Hoppe, F; Romalo, G; Schwab, B; Schweikert, HU | 1 |
Govindan, MV; Koutsilieris, M; Pagé, N; Warriar, N | 2 |
Mast, P; Oosterlinck, W | 1 |
Berrevoets, CA; Mulder, E; Veldscholte, J | 1 |
Heathcote, PS; Kateley, GD; Lloyd, S; Nicol, DL | 1 |
Cantabrana, B; Gutierrez, M; Hidalgo, A; Sánchez Aparicio, JA | 1 |
Elger, W; van der Schoot, P | 1 |
Sar, M; Wilson, EM; Wong, CI; Zhou, ZX | 1 |
McLeod, DG | 1 |
Denis, L | 2 |
Matzkin, H; Soloway, MS | 1 |
Benassayag, E | 1 |
Michna, H; Schneider, MR; Vollmer, G | 1 |
Acar, O; Goldschmidt, AJ; Tunn, UW | 1 |
Baisi, B; Castagnetti, G; Dotti, A; Ferrari, G; Ferrari, P | 1 |
Burnstein, KL; Cameron, DJ; Dai, JL; Maiorino, CA | 1 |
Shaw, JC | 1 |
Chukaev, SA | 1 |
Baamonde, A; Gutiérrez, M; Hidalgo, A; Menéndez, L; Ruiz-Gayo, M | 1 |
Gurpide, E; Markiewicz, L | 1 |
Schellhammer, PF | 1 |
de Voogt, H; Denis, L; Sylvester, RJ | 1 |
Bonnet, P | 1 |
Chang, C; Miyamoto, H; Wilding, G; Yeh, S | 1 |
Rai, U | 1 |
Coscia, EM; Drea, CM; Forger, NG; Frank, LG; Glickman, SE; Licht, P; Weldele, ML | 1 |
Newman, H; Olsen, I; Parkar, M; Tabona, P | 1 |
Sinclair, R; Young, R | 1 |
Cavazzini, P; degli Uberti, EC; del Senno, L; Fallo, F; Rossi, R; Valentini, A; Zatelli, MC | 1 |
Diamanti-Kandarakis, E | 1 |
Balsa, J; Escobar-Morreale, HF; Pazos, F; Sancho, JM; Varela, C | 1 |
Bersi, C; Fruzzetti, F; Genazzani, AR; Parrini, D; Ricci, C | 1 |
Bolla, M | 1 |
Bagnoli, A; Colombo, FM; Flamigni, C; Macrelli, S; Marescalchi, O; Paradisi, R; Ravaioli, B; Venturoli, S | 1 |
Chertin, B; Farkas, A; Lindenberg, T; Spitz, IM | 1 |
Rittmaster, RS | 1 |
Chen, J; Kao, JH; Lai, MK; Liu, CM; Pu, YS | 1 |
Bloemena, E; Hage, JJ; Kanhai, RC; Mulder, JW; van Diest, PJ | 1 |
Lumbroso, S; Moras, D; Nicolas, JC; Poujol, N; Sultan, C; Tahiri, B; Wurtz, JM | 1 |
Bruchovsky, N; Gleave, ME; Goldenberg, SL; Jones, EC; La Bianca, SE; Sullivan, LD | 1 |
Jones, GR; Lyng, FM; Rommerts, FF | 1 |
Danielsen, M; Harris, VK; List, HJ; Martinez, E; Riegel, AT; Smith, CL | 1 |
Gupta, C | 1 |
Gleave, M; Goldenberg, SL; Klotz, L | 1 |
Candas, B; Labrie, F | 1 |
Caruso, A; De Leo, V; Fulghesu, AM; la Marca, A; Morgante, G; Pasqui, L; Talluri, B; Torricelli, M | 1 |
Holst, M; Ritzén, EM; Svechnikov, K | 1 |
Collette, L; Denis, LJ; Schröder, FH; Studer, UE; Sylvester, RJ | 1 |
Butler, R; Gallo, JM; Leigh, PN | 1 |
Baniahmad, A; Cato, AC; Dotzlaw, H; Iñiguez Lluhí, JA; Mink, S; Moehren, U | 1 |
Jänne, OA; Karvonen, U; Palvimo, JJ | 1 |
Carmina, E; Lobo, RA | 2 |
Bonmassar, E; Faraoni, I; Missale, C; Rizzetti, MC; Sigala, S; Spano, P; Tognazzi, N | 1 |
Frame, SR; Ladics, GS; O'Connor, JC | 1 |
Butler, R; Darrington, RS; Gallo, JM; Leigh, PN; McPhaul, MJ | 1 |
Başogul, O; Inal, M; Ispahi, C; Karanfil, C; Onoglu, A; Taner, C; Tinar, S | 1 |
Collette, L; de Reijke, TM; Schröder, FH | 1 |
Skarda, J | 1 |
Cardi, A; Di Silverio, F; Sciarra, A | 1 |
Ajossa, S; Guerriero, S; Melis, GB; Orrù, M; Paoletti, AM | 1 |
Chang, LS; Chang, YH; Chen, KK; Chung, HJ; Hsu, YS; Huang, WJ; Kuo, JY; Lin, AD; Lin, AT; Wu, HH | 1 |
Collette, L; de Reijke, TM; Debois, M; Kurth, KH; Mattelaer, J; Pavone-Macaluso, M; Schröder, FH; van Velthoven, RF; Whelan, P | 1 |
Malstrom, SE; Meseguer, A; Purchio, AF; Tornavaca, O; West, DB | 1 |
Armonis, A; Avgerinos, A; Bethanis, S; Economou, M; Manolakopoulos, S; Tzourmakliotis, D | 1 |
Kelestimur, F; Sahin, Y | 1 |
Baltogiannis, D; Charalabopoulos, K; Giannakopoulos, X; Sofikitis, N | 1 |
Haroun, M | 1 |
Eckardt, KU; Effert, P; Grimm, MO; Kurtz, A; Voegeli, TA | 1 |
Al-Inany, H | 2 |
Ekinci, S; Ertunç, M; Onur, R; Tanyel, FC; Yildirim, M | 1 |
Hidalgo, A; Manso, G; Revuelta, P; Salgueiro, E; Thole, Z | 1 |
Asim, M; Baniahmad, A; Dotzlaw, H; Papaioannou, M; Reeb, C | 1 |
Inal, MM; Taner, CE; Yildirim, Y | 1 |
Chang, CY; Elbi, C; Hager, GL; Hendarwanto, A; Klokk, TI; Kurys, P; Nagaich, AK; Saatcioglu, F; Slagsvold, T | 1 |
De Rosier, T; Eliason, HC; Ervin, KM; Gowda, K; Kupcho, KR; Marks, BD; Ozers, MS; Qadir, N; Riddle, SM; Shekhani, MS | 1 |
Corbould, A | 1 |
Nguyen, TV; Pike, CJ; Yao, M | 1 |
Hara, S; Hyochi, N; Isaacs, JT; Ishioka, J; Kageyama, Y; Kihara, K; Singh, P; Urushibara, M | 1 |
Costa, J; Miquel, M; Ojanguren, I; Planas, R; Soler, A; Vaqué, A | 1 |
Conway, GS; Koulouri, O | 1 |
Aral, Y; Bavbek, N; Culha, C; Demirbas, B; Güler, S; Karakurt, F; Sahin, I; Serter, R | 1 |
Scheinfeld, N | 1 |
Clarke, S; George, R; Thiboutot, D | 1 |
Dubbink, HJ; Hersmus, R; Jenster, G; Lusher, SJ; Molier, M; Trapman, J; van de Wijngaart, DJ | 1 |
Bachelot, A; Chabbert-Buffet, N; Galand-Portier, MB; Kerlan, V; Salenave, S | 1 |
de Zegher, F; Diaz, M; Ibáñez, L; Lopez-Bermejo, A; Salvador, C; Sánchez-Infantes, D; Sebastiani, G | 1 |
Chacón, MR; de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Maymó-Masip, E; Salvador, C; Vendrell, J | 1 |
Açmaz, G; Boztosun, A; Müderris, II; Ozturk, A | 1 |
Karaca, Z; Kelestimur, F; Unluhizarci, K | 1 |
Bastide, C; Bruyère, F; Guy, L; Karsenty, G; Rozet, F | 1 |
Bettoli, V; Virgili, A; Zauli, S | 1 |
Begum, S; Bevan, CL; Brooke, GN; Bryan, RA; Dart, DA; Fioretti, FM; Gamble, SC; Hough, MA; Odontiadis, M; Powell, SM; Wait, R; Waxman, J | 1 |
Carter, B; Fedorowicz, Z; Pandis, N; van Zuuren, EJ | 1 |
Ioannides, D; Lazaridou, E | 1 |
de Zegher, F; Díaz, M; Gallego-Escuredo, JM; Ibáñez, L; Villarroya, F | 1 |
Fedorowicz, Z; van Zuuren, EJ | 1 |
Chahal, DS; Hassoun, LA; Larsen, LN; Sivamani, RK | 1 |
39 review(s) available for cyproterone acetate and flutamide
Article | Year |
---|---|
Cancer of the prostate. Mechanisms of action of antiandrogens.
Topics: Androgen Antagonists; Animals; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Rats; Testosterone | 1991 |
Antiandrogenic substances in the management of prostatic cancer.
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Male; Prostatic Neoplasms | 1990 |
Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma.
Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Prospective Studies; Prostatic Neoplasms; Tosyl Compounds | 1990 |
Clinical applications of antiandrogens.
Topics: Androgen Antagonists; Breast Neoplasms; Cyproterone; Cyproterone Acetate; Female; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Prostatic Hyperplasia; Prostatic Neoplasms; Puberty, Precocious; Skin Diseases; Spironolactone | 1988 |
Initiation of LHRH monotherapy for prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Prostatic Neoplasms | 1989 |
[Antiandrogens. Mechanisms and paradoxical effects].
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgens; Anilides; Cimetidine; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Nitriles; Spironolactone; Tosyl Compounds | 1989 |
Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma.
Topics: Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Male; Megestrol; Megestrol Acetate; Prostatic Neoplasms | 1988 |
Treatment of advanced prostatic cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Estrogens; Flutamide; Glucocorticoids; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms; Spironolactone; Time Factors | 1987 |
Advantages and disadvantages of pure antiandrogens and of antiandrogens of the cyproterone acetate-type in the treatment of prostatic cancer.
Topics: Androgen Antagonists; Animals; Cyproterone; Cyproterone Acetate; Female; Flutamide; Glucuronidase; Gonadotropin-Releasing Hormone; Guinea Pigs; Kidney; Male; Mice; Prostatic Neoplasms; Rats; Sex Differentiation; Time Factors | 1988 |
[LHRH agonists combined with antiandrogens in the treatment of metastasizing prostatic carcinoma].
Topics: Androgen Antagonists; Animals; Buserelin; Cyproterone; Cyproterone Acetate; Dogs; Drug Therapy, Combination; Flutamide; Humans; Male; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Rats; Receptors, Cell Surface; Receptors, LHRH | 1985 |
New forms and future perspectives in endocrine treatment of prostatic carcinoma.
Topics: Aminoglutethimide; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Estrogen Antagonists; Flutamide; Hormones; Humans; Male; Pituitary Hormone-Releasing Hormones; Prolactin; Prostatic Neoplasms | 1984 |
[Hormonal therapy of benign prostatic hyperplasia].
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Androgen Antagonists; Clinical Trials as Topic; Cyproterone Acetate; Flutamide; Humans; Male; Middle Aged; Prostate; Prostatic Hyperplasia; Urinary Bladder Neck Obstruction; Urodynamics | 1995 |
Total androgen blockade in the treatment of hormone-resistant metastasized prostate carcinoma. A literature review.
Topics: Androgen Antagonists; Cyproterone Acetate; Flutamide; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms | 1994 |
Antiandrogenic drugs.
Topics: Androgen Receptor Antagonists; Anilides; Cyproterone Acetate; Diethylstilbestrol; Drug Administration Schedule; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Megestrol; Megestrol Acetate; Nitriles; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Tosyl Compounds | 1993 |
Prostate cancer. Primary hormonal treatment.
Topics: Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Dihydrotestosterone; Estrogens; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Orchiectomy; Patient Participation; Prostate; Prostatic Neoplasms; Receptors, Androgen; Testosterone | 1993 |
Antiandrogenic agents as monotherapy in advanced prostatic carcinoma.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Neoplasm Staging; Nitriles; Prognosis; Prostatic Neoplasms; Testosterone; Tosyl Compounds | 1993 |
Antiandrogen therapy in dermatology.
Topics: Adrenal Cortex Hormones; Androgen Antagonists; Cimetidine; Contraceptives, Oral; Cyproterone Acetate; Finasteride; Flutamide; Humans; Ketoconazole; Skin Diseases; Spironolactone | 1996 |
The place and the results of monotherapy.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 1998 |
Hirsutes. II: Treatment.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androgen Receptor Antagonists; Contraceptives, Oral; Cosmetics; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Flutamide; Glucocorticoids; Gonadotropin-Releasing Hormone; Hair Removal; Hirsutism; Humans; Laser Therapy; Mineralocorticoid Receptor Antagonists; Prednisolone; Spironolactone | 1998 |
Antiandrogens as monotherapy for prostate cancer.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Prostatic Neoplasms; Tosyl Compounds | 1998 |
How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?
Topics: Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Flutamide; Humans; Polycystic Ovary Syndrome | 1998 |
Antiandrogen treatment of polycystic ovary syndrome.
Topics: Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Spironolactone | 1999 |
Neoadjuvant hormone therapy: the Canadian trials.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Canada; Cyproterone Acetate; Disease Progression; Flutamide; Humans; Leuprolide; Male; Neoadjuvant Therapy; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Rate | 2000 |
Antiandrogen monotherapy: recommendations for the treatment of prostate cancer.
Topics: Androgen Antagonists; Anilides; Chemotherapy, Adjuvant; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Orchiectomy; Prostatic Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Tosyl Compounds | 2004 |
Medical treatment regimens of hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Spironolactone | 2004 |
Monotherapy in advanced prostate cancer: an overview.
Topics: Adenocarcinoma; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cyproterone Acetate; Dihydrotestosterone; Estrogens; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Nitriles; Orchiectomy; Palliative Care; Progesterone Congeners; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Testosterone; Tosyl Compounds | 2004 |
Hormonal therapy of acne.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androgens; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Female; Flutamide; Humans; Middle Aged; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2004 |
Polycystic ovary syndrome.
Topics: Cyproterone Acetate; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Metformin; Polycystic Ovary Syndrome; Spironolactone | 2005 |
A systematic review of commonly used medical treatments for hirsutism in women.
Topics: Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Hirsutism; Humans; Metformin; Spironolactone; Thiazolidinediones; Treatment Outcome | 2008 |
A review of hormonal therapy for female pattern (androgenic) alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Dermatologic Agents; Enzyme Inhibitors; Female; Finasteride; Flutamide; Humans; Minoxidil; Spironolactone; Testosterone | 2008 |
Hormonal therapy for acne.
Topics: Acne Vulgaris; Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Female; Flutamide; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone | 2008 |
Anti-androgen treatments.
Topics: Androgen Antagonists; Cyproterone Acetate; Estrogens; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Progestins; Spironolactone | 2010 |
[Hormonal treatment in prostate cancer].
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Antineoplastic Agents, Hormonal; Benzamides; Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Estrogens, Non-Steroidal; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazolidines; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Oligopeptides; Phenylthiohydantoin; Prostatectomy; Prostatic Neoplasms | 2013 |
Is hormonal treatment still an option in acne today?
Topics: Acne Vulgaris; Adrenal Cortex Hormones; Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Female; Flutamide; Gonadotropin-Releasing Hormone; Hormones; Humans; Hyperandrogenism; Spironolactone | 2015 |
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Body Mass Index; Contraceptive Agents, Female; Cyproterone Acetate; Desogestrel; Drug Combinations; Eflornithine; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Quality of Life; Randomized Controlled Trials as Topic; Spironolactone | 2015 |
Female pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents | 2015 |
Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Androgen Antagonists; Body Mass Index; Contraceptives, Oral; Cyproterone Acetate; Drug Therapy, Combination; Female; Finasteride; Flutamide; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Hyperandrogenism; Hypoglycemic Agents; Polycystic Ovary Syndrome; Quality of Life; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Spironolactone; Treatment Outcome; Young Adult | 2016 |
The use of hormonal agents in the treatment of acne.
Topics: Acne Vulgaris; Administration, Oral; Contraceptive Agents; Cortodoxone; Cyproterone Acetate; Dermatologic Agents; Female; Finasteride; Flutamide; Hormones; Humans; Male; Meta-Analysis as Topic; Mineralocorticoid Receptor Antagonists; Propionates; Spironolactone; Treatment Outcome | 2016 |
31 trial(s) available for cyproterone acetate and flutamide
Article | Year |
---|---|
Advanced prostatic cancer: clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate.
Topics: Aged; Androgen Antagonists; Anilides; Buserelin; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Random Allocation | 1990 |
Antiandrogens: clinical applications.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Female; Flutamide; Hirsutism; Humans; Male; Prostatic Neoplasms; Spironolactone | 1990 |
Pure antiandrogens as monotherapy in prospective studies of prostatic carcinoma.
Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Nitriles; Prospective Studies; Prostatic Neoplasms; Tosyl Compounds | 1990 |
Effects of two different medical treatments on dihydrotestosterone content and androgen receptors in human benign prostatic hyperplasia.
Topics: Androgen Antagonists; Anilides; Cell Nucleus; Cyproterone; Cyproterone Acetate; Cytosol; Dihydrotestosterone; Flutamide; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Androgen; Tamoxifen | 1988 |
Short-term anti-androgen therapy and very long-acting depot gonadotrophin-releasing hormone agonist for prostatic cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Buserelin; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Flutamide; Humans; Male; Middle Aged; Prostatic Neoplasms; Random Allocation | 1989 |
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogue.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Flutamide; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Phosphoric Monoester Hydrolases; Prostatic Neoplasms; Random Allocation; Testosterone | 1988 |
Treatment of advanced prostatic cancer.
Topics: Adrenalectomy; Aminoglutethimide; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Estrogens; Flutamide; Glucocorticoids; Humans; Ketoconazole; Male; Megestrol; Megestrol Acetate; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms; Spironolactone; Time Factors | 1987 |
The effect of short term treatment with cyproterone acetate or flutamide on the metabolism of 5 alpha-dihydrotestosterone in human testicular tissue.
Topics: Aged; Aged, 80 and over; Anilides; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Humans; Male; Middle Aged; Testis | 1988 |
Total androgen blockade in advanced prostatic cancer. Critical review and personal experience.
Topics: Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Flutamide; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms; Time Factors | 1988 |
Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men.
Topics: Adult; Anilides; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Estradiol; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Pituitary Function Tests; Pituitary Hormones; Prolactin; Testicular Hormones; Testosterone | 1984 |
Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents; Biomarkers, Tumor; Chemotherapy, Adjuvant; Cyproterone Acetate; Diethylstilbestrol; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Testosterone; Time Factors | 1996 |
[Indications of antiandrogens in benign hyperplasia of the prostate].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Prostatic Hyperplasia | 1995 |
Effects of androgen deprivation prior to radical prostatectomy in 375 patients.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cyproterone Acetate; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Staging; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Time Factors | 1996 |
Combination treatment versus LHRH alone in advanced prostatic cancer.
Topics: Age Distribution; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyproterone Acetate; Flutamide; Follow-Up Studies; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms; Survival Rate | 1996 |
The importance of prognostic factors in the interpretation of two EORTC metastatic prostate cancer trials. European Organization for Research and Treatment of Cancer (EORTC) Genito-Urinary Tract Cancer Cooperative Group.
Topics: Aged; Analysis of Variance; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone Acetate; Disease-Free Survival; Flutamide; Goserelin; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Orchiectomy; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Survival Rate | 1998 |
European Organization for Research and Treatment of Cancer (EORTC) prostate cancer trials, 1976-1996.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Castration; Cyproterone Acetate; Diethylstilbestrol; Doxorubicin; Epirubicin; Estramustine; Flutamide; Humans; Imidazoles; Male; Medroxyprogesterone Acetate; Methotrexate; Mitomycin; Neoplasms, Hormone-Dependent; Procarbazine; Prostatic Neoplasms; Vindesine | 1998 |
Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
Topics: Adult; Androgen Antagonists; Body Mass Index; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Liver Function Tests; Luteolytic Agents; Prospective Studies; Triptorelin Pamoate | 1999 |
Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Hormones; Humans; Hyperandrogenism | 1999 |
Adjuvant hormonal treatment with radiotherapy for locally advanced prostate cancer.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cyproterone Acetate; Disease-Free Survival; Flutamide; Humans; Male; Neoplasm Staging; Prostatic Neoplasms | 1999 |
A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
Topics: Adult; Cyproterone Acetate; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Hormones; Humans; Ketoconazole; Prospective Studies | 1999 |
Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
Topics: Adult; Amenorrhea; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol; Estradiol Congeners; Estrone; Ethinyl Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Luteinizing Hormone; Luteolytic Agents; Polycystic Ovary Syndrome; Progesterone Congeners; Prospective Studies; Triptorelin Pamoate | 2000 |
A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Female; Finasteride; Flutamide; Humans; Hyperandrogenism; Prospective Studies; Statistics, Nonparametric | 2002 |
Treatment of hyperandrogenic alopecia in women.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Androgen Antagonists; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Humans; Hyperandrogenism; Italy; Liver; Testosterone | 2003 |
Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
Topics: Administration, Oral; Adult; Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Administration Schedule; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Liver Function Tests; Prolactin; Severity of Illness Index; Testosterone; Treatment Outcome | 2002 |
Prostate specific antigen: a prognostic marker of survival in good prognosis metastatic prostate cancer? (EORTC 30892).
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Neoplasms; Cyproterone Acetate; Disease Progression; Flutamide; Humans; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity; Soft Tissue Neoplasms; Survival Analysis | 2003 |
Metastatic prostate cancer treated by flutamide versus cyproterone acetate. Final analysis of the "European Organization for Research and Treatment of Cancer" (EORTC) Protocol 30892.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Disease Progression; Flutamide; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Survival Rate | 2004 |
Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Diuretics; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Treatment Outcome | 2005 |
Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Lipids; Prospective Studies; Spironolactone; Young Adult | 2008 |
Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.
Topics: Abdominal Fat; Adolescent; Androgen Antagonists; Body Composition; Cyproterone Acetate; Drug Combinations; Estrogens; Ethinyl Estradiol; Female; Flutamide; Humans; Hyperandrogenism; Hyperinsulinism; Hypoglycemic Agents; Metformin; Pioglitazone; Thiazolidinediones; Treatment Outcome | 2011 |
Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue.
Topics: Abdominal Fat; Adolescent; Androgen Antagonists; Angiopoietin-Like Protein 4; Angiopoietins; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Body Composition; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Flutamide; Gene Expression; Humans; Hyperandrogenism; Hypoglycemic Agents; Leptin; Metformin; Pioglitazone; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Subcutaneous Fat; Thiazolidinediones; TWEAK Receptor | 2012 |
Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess.
Topics: Adolescent; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Fibroblast Growth Factors; Flutamide; Hirsutism; Humans; Hyperandrogenism; Hyperinsulinism; Longitudinal Studies; Metformin; Pioglitazone; Thiazolidinediones | 2016 |
104 other study(ies) available for cyproterone acetate and flutamide
Article | Year |
---|---|
Antiandrogenic steroidal sulfonylpyrazoles.
Topics: Androgen Antagonists; Animals; Male; Molecular Structure; Orchiectomy; Organ Size; Pregnanes; Prostate; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, Androgen; Structure-Activity Relationship; Testosterone; X-Ray Diffraction | 1990 |
Identification of a lead pharmacophore for the development of potent nuclear receptor modulators as anticancer and X syndrome disease therapeutic agents.
Topics: Antineoplastic Agents; Cell Line; Chemistry, Pharmaceutical; Chenodeoxycholic Acid; DNA-Binding Proteins; Drug Design; Genes, Reporter; Humans; Metabolic Syndrome; Models, Chemical; Models, Molecular; Neoplasms; Protein Binding; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Transcriptional Activation; Transfection; Two-Hybrid System Techniques | 2006 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
NK cell activity in treated prostate cancer patients as a probe for circulating tumor cells: hormone regulatory effects in vivo.
Topics: Acid Phosphatase; Antineoplastic Agents; Biomarkers, Tumor; Cyproterone Acetate; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Diethylstilbestrol; Estradiol; Estramustine; Flutamide; Hormones; Humans; Hydrocortisone; Killer Cells, Natural; Male; Orchiectomy; Prolactin; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunoassay; Testosterone | 1992 |
[Non-surgical treatment of benign prostatic hypertrophy. Current status of the problem].
Topics: Androgen Antagonists; Aromatase Inhibitors; Cholestenone 5 alpha-Reductase; Cyproterone Acetate; Enzyme Inhibitors; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Oxidoreductases; Progestins; Prostatic Hyperplasia | 1992 |
Testosterone-induced suppression of self-healing Plasmodium chabaudi malaria: an effect not mediated by androgen receptors?
Topics: Animals; Cyproterone Acetate; Female; Flutamide; Malaria; Male; Mice; Mice, Inbred Strains; Orchiectomy; Receptors, Androgen; Testosterone | 1992 |
[A 79-year-old man with metastatic prostate cancer, treated with Zoladex, flutamide, calcitonin and Ostac, suffers from frequent troublesome sweating with palpitation and angina pectoris, especially at night. Is there a therapy?].
Topics: Aged; Androgen Antagonists; Angina Pectoris; Buserelin; Calcitonin; Cyproterone; Cyproterone Acetate; Flutamide; Goserelin; Humans; Hyperhidrosis; Male; Prostatic Neoplasms | 1992 |
[A study of the androgenic activity of anti-androgen].
Topics: Androgen Antagonists; Aniline Compounds; Animals; Arginase; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Estradiol; Flutamide; Male; Medroxyprogesterone; Organ Size; Ornithine Decarboxylase; Prostate; Rats; Rats, Inbred Strains; Receptors, Androgen; Seminal Vesicles | 1990 |
Investigation on serum neurone-specific enolase in prostate cancer diagnosis and monitoring: comparative study of a multiple tumor marker assay.
Topics: Acid Phosphatase; Antigens, Neoplasm; Antineoplastic Agents; APUD Cells; Biomarkers, Tumor; Carcinoembryonic Antigen; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estramustine; Flutamide; Humans; Male; Orchiectomy; Phosphopyruvate Hydratase; Prostate-Specific Antigen; Prostatic Neoplasms | 1991 |
Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Luteinizing Hormone; Male; Premedication; Prostatic Neoplasms; Testosterone; Time Factors | 1990 |
The synthetic androgen mibolerone induces transient suppression of the transformed phenotype in an androgen responsive human prostatic carcinoma cell line.
Topics: Androgen Antagonists; Androgens; Cell Division; Cell Transformation, Neoplastic; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Humans; Male; Nandrolone; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Tumor Cells, Cultured | 1990 |
Analysis of the androgenic activity of synthetic "progestins" currently used for the treatment of prostate cancer.
Topics: Adrenal Glands; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Organ Size; Ornithine Decarboxylase; Progesterone Congeners; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Spironolactone | 1987 |
Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice.
Topics: Androgens; Animals; Chlormadinone Acetate; Cyproterone; Cyproterone Acetate; Female; Flutamide; Male; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Mice; Progesterone Congeners; Prostatic Neoplasms | 1988 |
Treatment with antiandrogens induces an androgen-repressed gene in the rat ventral prostate.
Topics: Androgen Antagonists; Androgens; Animals; Blotting, Northern; Body Weight; Cell Survival; Cell-Free System; Cyproterone; Cyproterone Acetate; Flutamide; Gene Expression Regulation; Male; Orchiectomy; Organ Size; Prostate; Protein Biosynthesis; Rats; Rats, Inbred Strains; RNA | 1988 |
Androgens directly stimulate proliferation of bone cells in vitro.
Topics: Alkaline Phosphatase; Androgens; Animals; Binding, Competitive; Cell Count; Cell Differentiation; Cell Division; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; DNA; Dose-Response Relationship, Drug; Fluoxymesterone; Flutamide; Humans; Methenolone; Mice; Osteoblasts; Testosterone; Tumor Cells, Cultured | 1989 |
Antiandrogens do not reverse androgen-induced inhibition of sex hormone-binding globulin levels in adult female rhesus monkeys.
Topics: Androgen Antagonists; Androgens; Animals; Biomarkers; Cyproterone; Cyproterone Acetate; Female; Flutamide; Macaca; Macaca mulatta; Methyltestosterone; Ovariectomy; Pregnanes; Pyrazoles; Sex Hormone-Binding Globulin | 1989 |
Sexual dimorphism of blood pressure in spontaneously hypertensive rats: effects of anti-androgen treatment.
Topics: Androgen Antagonists; Anilides; Animals; Animals, Newborn; Blood Pressure; Cyproterone; Cyproterone Acetate; Female; Flutamide; Male; Orchiectomy; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sex Characteristics; Species Specificity; Testosterone | 1989 |
Effect of antiandrogens on some key enzymes of glycolysis in epididymis and ventral prostate of rat.
Topics: Androgen Antagonists; Animals; Body Weight; Cyproterone; Cyproterone Acetate; Enzymes; Epididymis; Estradiol; Flutamide; Glycolysis; Male; Nandrolone; Organ Size; Prostate; Rats | 1989 |
"Casodex" (ICI 176,334)--a new, pure, peripherally-selective anti-androgen: preclinical studies.
Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Dogs; Flutamide; Imidazoles; Imidazolidines; Male; Nitriles; Prostatic Neoplasms; Rats; Tosyl Compounds | 1989 |
[Antiandrogens in monotherapy or combined therapy for treatment of advanced cancer of the prostate].
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Antineoplastic Agents; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Flutamide; Follow-Up Studies; Humans; Imidazoles; Imidazolidines; Male; Middle Aged; Neoplasm Staging; Nitriles; Orchiectomy; Prostatic Neoplasms; Tosyl Compounds | 1989 |
Onset of steroidogenesis and differentiation of functional LH receptors in rat fetal testicular cultures.
Topics: Aminoglutethimide; Animals; Binding, Competitive; Bucladesine; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Flutamide; Gestational Age; Luteinizing Hormone; Male; Organ Culture Techniques; Progesterone; Rats; Rats, Inbred Strains; Receptors, LH; Testis; Testosterone | 1987 |
Testosterone suppression of ornithine decarboxylase activity in rat Sertoli cells.
Topics: Animals; Bucladesine; Cells, Cultured; Cyclic AMP; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Enzyme Induction; Estradiol; Flutamide; Follicle Stimulating Hormone; Male; Ornithine Decarboxylase; Rats; Rats, Inbred Strains; Sertoli Cells; Testosterone | 1988 |
Effect of antiandrogens on the hypothalamic gamma-aminobutyric acid (GABA) and glutamate contents of the Indian palm squirrel (Funambulus pennanti, Wroughton).
Topics: Androgen Antagonists; Animals; Cyproterone; Cyproterone Acetate; Female; Flutamide; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Hypothalamus; Organ Size; Sciuridae | 1986 |
Treatment of prostatic cancer. Newer forms of androgen deprivation.
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Male; Megestrol; Megestrol Acetate; Neoplasm Metastasis; Orchiectomy; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms | 1986 |
Effects of cyproterone acetate and flutamide on the testis and epididymis of the Indian wall lizard, Hemidactylus flaviviridis (Ruppell).
Topics: Anilides; Animals; Cyproterone; Cyproterone Acetate; Epididymis; Epithelial Cells; Flutamide; Leydig Cells; Lizards; Male; Organ Size; Spermatogenesis; Spermatozoa; Testis | 1986 |
Inhibition of testosterone metabolism in the brain and cloacal gland of the quail by specific inhibitors and antihormones.
Topics: Androgen Antagonists; Androstanes; Androstatrienes; Animals; Azasteroids; Cloaca; Coturnix; Cyproterone; Cyproterone Acetate; Estrogen Antagonists; Flutamide; Hypothalamus; Male; Nitromifene; Quail; Tamoxifen; Testosterone | 1987 |
Acid phosphatase activity: a marker of androgen action in prostate explant cultures.
Topics: Acid Phosphatase; Animals; Cells, Cultured; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Flutamide; Hydrocortisone; Male; Prostate; Rats; Rats, Inbred Strains | 1987 |
Effects of metabolism inhibitors, antiestrogens and antiandrogens on the androgen and estrogen induced sexual behavior in Japanese quail.
Topics: Androgens; Androstatrienes; Animals; Coturnix; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Estrogens; Flutamide; Male; Orchiectomy; Quail; Sexual Behavior, Animal; Tamoxifen; Testosterone | 1986 |
[Effects of cyproterone acetate and flutamide on blood calcium and bone structure].
Topics: Androgen Antagonists; Anilides; Animals; Bone and Bones; Calcium; Cyproterone; Cyproterone Acetate; Flutamide; Male; Rats; Rats, Inbred Strains | 1986 |
Inhibition of rat testicular 17 alpha-hydroxylase and 17,20-lyase activities by anti-androgens (flutamide, hydroxyflutamide, RU23908, cyproterone acetate) in vitro.
Topics: Aldehyde-Lyases; Androgen Antagonists; Animals; Cyproterone; Cyproterone Acetate; Cytochrome P-450 Enzyme System; Flutamide; Imidazoles; Imidazolidines; Kinetics; Male; Microsomes; Rats; Rats, Inbred Strains; Steroid 17-alpha-Hydroxylase; Steroid Hydroxylases; Testis | 1987 |
The kinetics of antiandrogens in humans.
Topics: Androgen Antagonists; Anilides; Cyproterone; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Prostatic Neoplasms | 1987 |
Effect of cyproterone acetate in comparison to flutamide and megestrol acetate on the ventral prostate, seminal vesicle, and adrenal glands of adult male rats.
Topics: Adrenal Glands; Androgen Antagonists; Animals; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Dose-Response Relationship, Drug; Flutamide; Male; Megestrol; Megestrol Acetate; Orchiectomy; Organ Size; Prostate; Rats; Rats, Inbred Strains; Seminal Vesicles | 1987 |
ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen.
Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Dogs; Flutamide; Imidazoles; Imidazolidines; Male; Nitriles; Prostate; Radioligand Assay; Rats; Receptors, Androgen; Seminal Vesicles; Testosterone; Tosyl Compounds | 1988 |
Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.
Topics: Anilides; Animals; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Dihydrotestosterone; Flutamide; Gonadotropin-Releasing Hormone; Imidazoles; Imidazolidines; Leuprolide; Male; Megestrol; Megestrol Acetate; Orchiectomy; Prostate; Rats; Rats, Inbred Strains; Receptors, Androgen | 1988 |
Microsomal effects of cyproterone acetate and flutamide in rat testis.
Topics: Androgen Antagonists; Anilides; Animals; Cyproterone; Cyproterone Acetate; Cytochrome b Group; Cytochrome P-450 Enzyme System; Cytochromes b5; Flutamide; In Vitro Techniques; Luteinizing Hormone; Male; Microsomes; NADPH-Ferrihemoprotein Reductase; Rats; Rats, Inbred Strains; Testis; Testosterone | 1988 |
Stimulation of ribonucleic acid polymerase activity in mouse kidney.
Topics: Animals; Cyproterone; Cyproterone Acetate; DNA-Directed RNA Polymerases; Female; Flutamide; Kidney; Medroxyprogesterone; Mice; Mice, Inbred C57BL; Progesterone; Receptors, Androgen; Receptors, Steroid; RNA Polymerase I; RNA Polymerase II; Testosterone | 1983 |
Effect of 17-hydroxy progesterone caproate, flutamide & cyproterone acetate on genital organs & fertility of male rats--a comparative study.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Anilides; Animals; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Fertility; Flutamide; Genitalia, Male; Hydroxyprogesterones; Male; Organ Specificity; Progesterone Congeners; Rats | 1980 |
Pubertal induction of sweat gland activity.
Topics: Acne Vulgaris; Adult; Child; Cyproterone; Cyproterone Acetate; Female; Flutamide; Humans; Male; Middle Aged; Puberty; Sex Factors; Sweat Glands; Sweating; Testosterone | 1981 |
Sex-specific action of antiandrogens on androgen induced changes in hepatic microsomal 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase activity in the rat.
Topics: 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androgen Antagonists; Anilides; Animals; Castration; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Female; Flutamide; Male; Microsomes, Liver; Organ Size; Oxidoreductases; Rats; Sex Factors | 1981 |
Effects of antiandrogens on glycogen metabolism of spermatozoa from caput epididymidis.
Topics: Anilides; Animals; Contraceptive Agents, Male; Cyproterone; Cyproterone Acetate; Flutamide; Glycogen; Male; Mice; Spermatozoa | 1981 |
Androgen ablation induces tenascin expression in the rat prostate.
Topics: Androgen Antagonists; Anilides; Animals; Cell Adhesion Molecules, Neuronal; Cyproterone Acetate; Extracellular Matrix Proteins; Flutamide; Male; Nitriles; Orchiectomy; Prostate; Rats; Rats, Wistar; Tenascin; Testosterone; Tosyl Compounds | 1994 |
Bone alkaline phosphatase and prostate-specific antigen in the monitoring of prostate cancer.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Cyproterone Acetate; Diethylstilbestrol; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Isoenzymes; Male; Middle Aged; Monitoring, Physiologic; Neoplasm Staging; Orchiectomy; Probability; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Time Factors | 1994 |
[Studies of spermatogenic damages induced by anti-cancer agent and anti-androgenic agents in rat testes].
Topics: Androgen Antagonists; Animals; Cisplatin; Cyproterone Acetate; DNA Replication; Flutamide; Male; Rats; Rats, Sprague-Dawley; Spermatogenesis; Testis | 1995 |
Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitro.
Topics: Androgen Antagonists; Cell Division; Cyproterone Acetate; Dihydrotestosterone; Dose-Response Relationship, Drug; Finasteride; Flutamide; Humans; Linear Models; Male; Prostatic Neoplasms; Testosterone; Tumor Cells, Cultured | 1995 |
Juvenile nasopharyngeal fibroma: androgen receptors and their significance for tumor growth.
Topics: Cell Division; Child; Cholestenone 5 alpha-Reductase; Cyproterone; Cyproterone Acetate; Dihydrotestosterone; Fibroblasts; Fibroma; Flutamide; Humans; Male; Nasopharyngeal Neoplasms; Oxidoreductases; Receptors, Androgen; Scrotum; Skin; Testosterone; Tritium; Tumor Cells, Cultured | 1994 |
Antiandrogens inhibit human androgen receptor-dependent gene transcription activation in the human prostate cancer cells LNCaP.
Topics: Amino Acid Sequence; Androgen Antagonists; Binding, Competitive; Blotting, Western; Chloramphenicol O-Acetyltransferase; Cyproterone Acetate; Dihydrotestosterone; Dose-Response Relationship, Drug; Flutamide; Gene Expression Regulation, Viral; Humans; Imidazoles; Imidazolidines; Male; Mammary Tumor Virus, Mouse; Molecular Sequence Data; Promoter Regions, Genetic; Prostatic Neoplasms; Receptors, Androgen; Transcription, Genetic; Transfection; Tumor Cells, Cultured | 1994 |
Interaction of antiandrogen-androgen receptor complexes with DNA and transcription activation.
Topics: Androgen Antagonists; Animals; Binding, Competitive; Blotting, Western; Cell Line; Chloramphenicol O-Acetyltransferase; Chlorocebus aethiops; Cyproterone Acetate; Dihydrotestosterone; DNA; Flutamide; Gene Expression Regulation; Humans; Imidazoles; Imidazolidines; Kidney; Kinetics; Mammary Tumor Virus, Mouse; Metribolone; Receptors, Androgen; Recombinant Proteins; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection | 1993 |
Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.
Topics: Adenocarcinoma; Alanine; Amino Acid Sequence; Androgen Antagonists; Anilides; Animals; Blotting, Western; Cell Line; Cell Nucleus; Chloramphenicol O-Acetyltransferase; Cyproterone Acetate; Dose-Response Relationship, Drug; Flutamide; Humans; Male; Metribolone; Mutagenesis, Site-Directed; Nitriles; Point Mutation; Prostatic Neoplasms; Receptors, Androgen; Recombinant Proteins; Threonine; Tosyl Compounds; Transcription, Genetic; Transfection; Transformation, Genetic; Tumor Cells, Cultured | 1993 |
Advanced prostate cancer. The role of high priced hormone therapy.
Topics: Combined Modality Therapy; Cyproterone Acetate; Diagnosis-Related Groups; Drug Costs; Drug Therapy, Combination; Flutamide; Goserelin; Health Care Costs; Humans; Male; Orchiectomy; Prostatic Neoplasms; Queensland | 1993 |
Effects of androgens on isolated rat uterus.
Topics: Animals; Cycloheximide; Cyproterone Acetate; Dactinomycin; Dihydrotestosterone; Drug Interactions; Female; Flutamide; In Vitro Techniques; Muscle Contraction; Rats; Rats, Wistar; Uterus | 1993 |
Perinatal development of gubernacular cones in rats and rabbits: effect of exposure to anti-androgens.
Topics: Animals; Cyproterone Acetate; Female; Flutamide; Inguinal Canal; Male; Ovary; Rabbits; Rats; Rats, Sprague-Dawley; Rats, Wistar; Testis | 1993 |
Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains.
Topics: Androgens; Animals; Baculoviridae; Base Sequence; Binding Sites; Cell Line; Cyproterone Acetate; DNA; Flutamide; Genetic Vectors; Humans; Macromolecular Substances; Mifepristone; Molecular Sequence Data; Moths; Receptors, Androgen; Recombinant Proteins; Transfection | 1993 |
Tumorigenesis disrupts hormonal regulation of tenascin expression in regressing Dunning R 3327 H prostate carcinoma.
Topics: Androgen Antagonists; Animals; Cyproterone Acetate; Flutamide; Male; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate; Prostatic Neoplasms; Rats; Tenascin; Tumor Cells, Cultured | 1996 |
Androgen and glucocorticoid regulation of androgen receptor cDNA expression.
Topics: Cell Line; Cyproterone Acetate; Cytomegalovirus; DNA, Complementary; Dose-Response Relationship, Drug; Down-Regulation; Flutamide; Gene Expression; Glucocorticoids; Humans; Metribolone; Promoter Regions, Genetic; Protein Biosynthesis; Receptors, Androgen; Receptors, Glucocorticoid; RNA, Messenger; Testosterone Congeners; Time Factors; Transfection; Tumor Cells, Cultured | 1995 |
[The effect of antiandrogens cyproterone acetate and niftolide on free radical oxidation indices in model biological systems in vitro].
Topics: Androgen Antagonists; Animals; Antioxidants; Cyproterone Acetate; Flutamide; Free Radicals; In Vitro Techniques; Liposomes; Luminescent Measurements; Male; Oxidation-Reduction; Rats | 1996 |
Cyproterone acetate displaces opiate binding in mouse brain.
Topics: Androgen Antagonists; Animals; Binding, Competitive; Brain; Cyproterone Acetate; Dihydrotestosterone; Diprenorphine; Flutamide; Isotope Labeling; Lethal Dose 50; Male; Mice; Narcotic Antagonists; Progesterone; Receptors, Opioid | 1997 |
Estrogenic and progestagenic activities of physiologic and synthetic androgens, as measured by in vitro bioassays.
Topics: Adenocarcinoma; Alkaline Phosphatase; Androgen Antagonists; Androgens; Breast Neoplasms; Cyproterone Acetate; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Flutamide; Gonanes; Humans; Mifepristone; Polyunsaturated Alkamides; Progestins; Tamoxifen; Testosterone; Testosterone Congeners; Tumor Cells, Cultured | 1997 |
Fulminant hepatic failure associated with bicalutamide.
Topics: Androgen Antagonists; Anilides; Cyproterone Acetate; Flutamide; Hepatic Encephalopathy; Humans; Nitriles; Tosyl Compounds | 1997 |
Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells.
Topics: Androgen Antagonists; Androgens; Anilides; Cyproterone Acetate; Drug Interactions; Flutamide; Humans; Imidazoles; Male; Mifepristone; Nitriles; Nuclear Receptor Coactivators; Oncogene Proteins; Prostatic Neoplasms; Protein Binding; Protein Conformation; Tosyl Compounds; Trans-Activators; Transcription Factors; Transcriptional Activation; Tumor Cells, Cultured | 1998 |
Sex steroid hormones modulate the activation of murine peritoneal macrophages: receptor mediated modulation.
Topics: Animals; Castration; Cyproterone Acetate; Estradiol; Female; Flutamide; Gonadal Steroid Hormones; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Mifepristone; Nitrites; Progesterone; Receptors, Steroid; Tamoxifen; Testosterone | 1998 |
Androgens and masculinization of genitalia in the spotted hyaena (Crocuta crocuta). 2. Effects of prenatal anti-androgens.
Topics: 5-alpha Reductase Inhibitors; Androgen Antagonists; Androstenedione; Animals; Carnivora; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Flutamide; Genitalia; Male; Maternal-Fetal Exchange; Pregnancy; Sex Differentiation; Urogenital System | 1998 |
IL-6 expression by oral fibroblasts is regulated by androgen.
Topics: Androgen Antagonists; Cells, Cultured; Cyproterone Acetate; Dihydrotestosterone; Fibroblasts; Flutamide; Gene Expression Regulation; Gingiva; Humans; Interleukin-6 | 1998 |
Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells.
Topics: Adrenal Cortex; Androgen Antagonists; Cell Division; Cells, Cultured; Cyproterone Acetate; Dihydrotestosterone; Female; Flutamide; Gene Expression; Humans; Immunohistochemistry; Male; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured | 1998 |
Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Drug Implants; Drug Therapy, Combination; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 1999 |
Antiandrogen hepatotoxicity in patients with chronic viral hepatitis.
Topics: Aged; Androgen Antagonists; Chemical and Drug Induced Liver Injury; Cyproterone Acetate; Flutamide; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Incidence; Liver Diseases; Liver Function Tests; Male; Prostatic Neoplasms; Retrospective Studies | 1999 |
Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men.
Topics: Adult; Aged; Androgen Antagonists; Anilides; Breast; Castration; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Flutamide; Follow-Up Studies; Gynecomastia; Humans; Male; Mastectomy, Subcutaneous; Metaplasia; Nitriles; Orchiectomy; Time Factors; Tosyl Compounds; Transsexualism | 2000 |
Specific recognition of androgens by their nuclear receptor. A structure-function study.
Topics: Amino Acid Sequence; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Binding Sites; Computer Simulation; Cyproterone Acetate; Dose-Response Relationship, Drug; Flutamide; Humans; Ligands; Metribolone; Models, Molecular; Molecular Sequence Data; Nitriles; Progesterone; Promegestone; Receptors, Androgen; Sequence Alignment; Tosyl Compounds; Transcriptional Activation | 2000 |
Long-term neoadjuvant hormone therapy prior to radical prostatectomy: evaluation of risk for biochemical recurrence at 5-year follow-up.
Topics: Adult; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cyproterone Acetate; Diethylstilbestrol; Drug Therapy, Combination; Flutamide; Follow-Up Studies; Humans; Leuprolide; Lymph Node Excision; Male; Middle Aged; Neoadjuvant Therapy; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Recurrence; Treatment Outcome | 2000 |
Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
Topics: Androgen Antagonists; Androgens; Animals; Calcium Signaling; Cell Line; Cyproterone Acetate; Dihydrotestosterone; Dose-Response Relationship, Drug; Flutamide; Gap Junctions; Humans; Kinetics; Male; Metribolone; Prostate; Prostatic Neoplasms; Rats; Rats, Wistar; Sertoli Cells; Testosterone; Tumor Cells, Cultured | 2000 |
Effects of antiandrogens on chromatin remodeling and transcription of the integrated mouse mammary tumor virus promoter.
Topics: Androgen Antagonists; Animals; Base Sequence; Chromatin; Cyproterone Acetate; DNA Probes; Female; Flutamide; L Cells; Male; Mammary Tumor Virus, Mouse; Mice; Promoter Regions, Genetic; Receptors, Androgen; Transcriptional Activation | 2000 |
The role of estrogen receptor, androgen receptor and growth factors in diethylstilbestrol-induced programming of prostate differentiation.
Topics: Androgen Antagonists; Animals; Antibodies; Cyproterone Acetate; Diethylstilbestrol; Embryonic and Fetal Development; Epidermal Growth Factor; Estrogen Receptor Modulators; Estrogens, Non-Steroidal; Flutamide; Growth Substances; Male; Organ Culture Techniques; Prostate; Receptors, Androgen; Receptors, Estrogen; Sex Differentiation | 2000 |
Androgen blockade in prostate cancer.
Topics: Androgen Antagonists; Cyproterone Acetate; Flutamide; Humans; Imidazoles; Imidazolidines; Male; Meta-Analysis as Topic; Orchiectomy; Prostatic Neoplasms | 2000 |
Androgen and estrogen stimulation of ornithine decarboxylase activity in mouse kidney.
Topics: Androgen Antagonists; Animals; Cyproterone Acetate; Dichlorodiphenyl Dichloroethylene; Dihydrotestosterone; Estradiol; Female; Flutamide; Kidney; Mice; Mice, Inbred CBA; Ornithine Decarboxylase; Oxazoles; Spironolactone; Testosterone | 2000 |
Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences.
Topics: Androgen Antagonists; Anilides; Clinical Trials, Phase III as Topic; Cyproterone Acetate; Factor Analysis, Statistical; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Imidazoles; Imidazolidines; Leuprolide; Male; Meta-Analysis as Topic; Nitriles; Orchiectomy; Prognosis; Prostatic Neoplasms; Research Design; Survival Analysis; Tosyl Compounds; Treatment Outcome | 2001 |
Androgen-induced up-regulation of tubulin isoforms in neuroblastoma cells.
Topics: Androgen Antagonists; Animals; Blotting, Northern; Brain Chemistry; Cell Differentiation; Cyproterone Acetate; Flutamide; Humans; Immunoblotting; Liver; Mice; Microtubules; Neurons; Phosphoprotein Phosphatases; Protein Isoforms; Receptors, Androgen; tau Proteins; Testosterone; Tubulin; Tumor Cells, Cultured | 2001 |
The amino terminus of the human AR is target for corepressor action and antihormone agonism.
Topics: Androgen Antagonists; Anilides; Animals; Catalytic Domain; Cell Line; Cyclic AMP-Dependent Protein Kinases; Cyproterone Acetate; DNA-Binding Proteins; Flutamide; Haplorhini; Humans; Ligands; Male; Nitriles; Nuclear Receptor Co-Repressor 2; Point Mutation; Protein Conformation; Receptors, Androgen; Repressor Proteins; Tosyl Compounds; Transcriptional Activation; Transfection | 2002 |
Pure antiandrogens disrupt the recruitment of coactivator GRIP1 to colocalize with androgen receptor in nuclei.
Topics: Active Transport, Cell Nucleus; Androgen Antagonists; Androgens; Anilides; Animals; Cell Nucleus; Chlorocebus aethiops; COS Cells; Cyproterone Acetate; Flutamide; Nitriles; Nuclear Receptor Coactivator 2; Receptors, Androgen; Subcellular Fractions; Tosyl Compounds; Transcription Factors; Transcriptional Activation | 2002 |
Nerve growth factor induces the re-expression of functional androgen receptors and p75(NGFR) in the androgen-insensitive prostate cancer cell line DU145.
Topics: Androgen Antagonists; Androgens; Apoptosis; Cell Division; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Gene Expression; Humans; Male; Nerve Growth Factor; Prostatic Neoplasms; Receptor, Nerve Growth Factor; Receptors, Androgen; RNA, Messenger; Telomerase; Tumor Cells, Cultured | 2002 |
Evaluation of a 15-day screening assay using intact male rats for identifying antiandrogens.
Topics: Androgen Antagonists; Androgens; Animals; Body Weight; Cyproterone Acetate; Dichlorodiphenyl Dichloroethylene; Diethylhexyl Phthalate; Drug Evaluation, Preclinical; Flutamide; Immune System; Linuron; Male; Organ Size; Oxazoles; Rats; Rats, Sprague-Dawley; Thyroid Gland | 2002 |
Ligand-dependent aggregation of polyglutamine-expanded androgen receptor in neuronal cells.
Topics: Androgen Antagonists; Animals; Blotting, Western; Cell Line; Cyproterone Acetate; Estrogen Antagonists; Flutamide; Ligands; Mice; Microscopy, Fluorescence; Muscular Atrophy; Muscular Atrophy, Spinal; Neuroblastoma; Peptides; Receptors, Androgen; Tamoxifen; Testosterone; Transfection | 2002 |
Bioassay of steroid hormone agonist and antagonist activities of anti-androgens on mammary gland, seminal vesicles and spleen of male mice.
Topics: Androgen Antagonists; Anilides; Animals; Animals, Outbred Strains; Biological Assay; Chlormadinone Acetate; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Flutamide; Male; Mammary Glands, Animal; Mice; Mice, Inbred C3H; Nitriles; Norethindrone; Norethindrone Acetate; Orchiectomy; Progesterone; Seminal Vesicles; Spleen; Steroids; Tosyl Compounds | 2003 |
The treatment of polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cabergoline; Cardiovascular Diseases; Clomiphene; Cyproterone Acetate; Diabetes Complications; Dopamine Agonists; Ergolines; Female; Finasteride; Flutamide; Follicle Stimulating Hormone; Gonadotropins; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Insulin Resistance; Metformin; Mineralocorticoid Receptor Antagonists; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Risk Factors; Spironolactone; Weight Loss | 2004 |
Antiandrogen-associated hepatotoxicity in the management of advanced prostate cancer.
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Chemical and Drug Induced Liver Injury; Cyproterone Acetate; Flutamide; Gonadotropin-Releasing Hormone; Humans; Male; Orchiectomy; Prostatic Neoplasms; Time Factors | 2003 |
The characterization and hormonal regulation of kidney androgen-regulated protein (Kap)-luciferase transgenic mice.
Topics: Androgen Antagonists; Animals; Blotting, Western; Cyproterone Acetate; Female; Firefly Luciferin; Flutamide; Kidney; Luciferases; Luminescent Measurements; Male; Mice; Mice, Transgenic; Protein Biosynthesis; Proteins; Testosterone; Tissue Distribution | 2004 |
Toxic hepatitis after sequential administration of flutamide and cyproterone acetate.
Topics: Aged; Androgen Antagonists; Bilirubin; Chemical and Drug Induced Liver Injury; Cyproterone Acetate; Flutamide; Humans; Liver Function Tests; Male | 2004 |
Anemia under androgen deprivation: influence of flutamide, cyproteroneacetate and orchiectomy on the erythropoietin system.
Topics: Androgen Antagonists; Androgens; Anemia; Animals; Cyproterone Acetate; Erythropoietin; Flutamide; Hematopoiesis; Humans; Male; Orchiectomy; Prostatic Neoplasms; Rats; Rats, Wistar | 2005 |
Anti-androgen induced inhibition of testicular descent is associated with a decrease in sympathetic tonus.
Topics: Androgen Antagonists; Androgens; Animals; Cryptorchidism; Cyproterone Acetate; Flutamide; Isoproterenol; Male; Muscle Contraction; Rats; Sympathetic Nervous System; Testis | 2005 |
Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system.
Topics: Adverse Drug Reaction Reporting Systems; Androgen Antagonists; Anilides; Chemical and Drug Induced Liver Injury; Cyproterone Acetate; Flutamide; Humans; International Classification of Diseases; Liver Diseases; Nitriles; Retrospective Studies; Spain; Time Factors; Tosyl Compounds | 2006 |
Co-activator and co-repressor interplay on the human androgen receptor.
Topics: Androgen Antagonists; Androgen-Binding Protein; Androgens; Anilides; Cyproterone Acetate; Flutamide; Humans; Ligands; Male; Nitriles; Protein Binding; Receptors, Androgen; Repressor Proteins; Response Elements; Time Factors; Tosyl Compounds; Trans-Activators; Transcriptional Activation | 2005 |
Ligand-specific dynamics of the androgen receptor at its response element in living cells.
Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Animals; Cell Line, Tumor; Chromatin Assembly and Disassembly; Cyproterone Acetate; Dihydrotestosterone; Female; Fluorescence Recovery After Photobleaching; Flutamide; Genes, Reporter; Green Fluorescent Proteins; In Situ Hybridization, Fluorescence; Ligands; Luciferases; Mammary Neoplasms, Animal; Mammary Tumor Virus, Mouse; Metribolone; Mice; Microscopy, Video; Mifepristone; Models, Biological; Nitriles; Plasmids; Promoter Regions, Genetic; Receptors, Androgen; Response Elements; Testosterone; Tosyl Compounds; Transcription, Genetic | 2007 |
The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay.
Topics: Amino Acid Sequence; Amino Acid Substitution; Androgen Antagonists; Anilides; Animals; Cyproterone Acetate; Dihydrotestosterone; Fluoresceins; Fluorescence Resonance Energy Transfer; Flutamide; Ligands; Mifepristone; Nitriles; Oligopeptides; Rats; Receptors, Androgen; Tosyl Compounds | 2007 |
Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women.
Topics: Adipocytes; Adult; Analysis of Variance; Biological Transport; Cell Differentiation; Cells, Cultured; Cyproterone Acetate; Female; Flutamide; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Phosphoproteins; Phosphorylation; Polycystic Ovary Syndrome; Protein Kinase C; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Subcutaneous Fat; Testosterone | 2007 |
Flutamide and cyproterone acetate exert agonist effects: induction of androgen receptor-dependent neuroprotection.
Topics: Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Animals; Animals, Newborn; Cyproterone Acetate; Flutamide; Gene Expression Regulation; Molecular Mimicry; Neurons; Neuroprotective Agents; PC12 Cells; Rats; Rats, Sprague-Dawley; Receptors, Androgen | 2007 |
Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
Topics: Allylestrenol; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Anilides; Cyproterone Acetate; Flutamide; Humans; Imidazolidines; Male; Models, Molecular; Mutagenesis, Site-Directed; Neoplasms, Hormone-Dependent; Nitriles; Plasmids; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Testosterone; Tosyl Compounds; Transcription, Genetic; Transfection | 2007 |
Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
Topics: Acute Disease; Adenocarcinoma; Adrenal Cortex Hormones; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemical and Drug Induced Liver Injury; Cyproterone Acetate; Drug Monitoring; Flutamide; Humans; Liver; Liver Function Tests; Male; Prostatic Neoplasms; Severity of Illness Index; Treatment Outcome | 2007 |
Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701H.
Topics: Androgen Antagonists; Anilides; Blotting, Western; Cell Line, Tumor; Cyproterone Acetate; Dihydrotestosterone; Flutamide; Humans; Hydrocortisone; Hydrophobic and Hydrophilic Interactions; Male; Mutation; Nitriles; Progesterone; Prostatic Neoplasms; Protein Structure, Secondary; Receptors, Androgen; Steroids; Structure-Activity Relationship; Tosyl Compounds | 2010 |
Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Severity of Illness Index; Treatment Outcome; Women's Health; Young Adult | 2013 |
Hirsutism - from diagnosis to use of antiandrogens.
Topics: Androgen Antagonists; Androstenes; Cyproterone Acetate; Female; Finasteride; Flutamide; Hirsutism; Humans; Hyperandrogenism; Polycystic Ovary Syndrome; Spironolactone | 2013 |
Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.
Topics: Amino Acid Sequence; Androgen Antagonists; Anilides; Cell Line, Tumor; Cyproterone Acetate; Flutamide; Gene Expression Regulation, Neoplastic; Humans; Male; Molecular Sequence Annotation; Molecular Sequence Data; Mutation; Nandrolone; Neoplasm Proteins; Nitriles; Prostate; Proteome; Receptors, Androgen; Signal Transduction; Tosyl Compounds | 2015 |